Back
NovoCure Vs. Allegiant Travel Industry Stock Comparison
Sell
16
NVCR
NovoCure
Last Price:
14.72
Seasonality Move:
-2.38%
Buy
65
ALGT
Allegiant Travel
Last Price:
57.85
Seasonality Move:
11.89%
Sell
16
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $14.72. The Score for NVCR is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- NVCR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
65
Allegiant Travel (ALGT)
is a Buy
Is Allegiant Travel a Buy, Sell or Hold?
- The current Allegiant Travel [ALGT] share price is $57.81. The Score for ALGT is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- ALGT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVCR Stock Price Chart
ALGT Stock Price Chart
What is Allegiant Travel's stock price today?
-
The Allegiant Travel share price today is $57.81
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGT is experiencing slight buying pressure.
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.85 | Sell |
| Relative Strength Index (14 RSI): | 35.27 | Sell |
| Chaikin Money Flow: | -113384 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.53 - 17.97) | Sell |
| Bollinger Bands (100): | (16.67 - 21.29) | Sell |
ALGT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.64 | Buy |
| Relative Strength Index (14 RSI): | 75.53 | Buy |
| Chaikin Money Flow: | 31717 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.16 - 51.88) | Buy |
| Bollinger Bands (100): | (42.2 - 53.32) | Buy |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.31 | Sell |
| 20-day SMA: | 16.55 | Sell |
| 50-day SMA: | 17.97 | Sell |
| 200-day SMA: | 16.69 | Sell |
| 8-day EMA: | 15.37 | Sell |
| 20-day EMA: | 16.28 | Sell |
| 50-day EMA: | 17.31 | Sell |
| 200-day EMA: | 19.72 | Sell |
ALGT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.64 | Buy |
| 20-day SMA: | 47.26 | Buy |
| 50-day SMA: | 44.58 | Buy |
| 200-day SMA: | 59.64 | Sell |
| 8-day EMA: | 53.72 | Buy |
| 20-day EMA: | 49.31 | Buy |
| 50-day EMA: | 46.99 | Buy |
| 200-day EMA: | 57.76 | Buy |
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and a decrease next year of $0.12 per share.
Allegiant Travel Earnings Growth & ALGT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.94 per share, and an increase next year of $4.74 per share.
NovoCure Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Allegiant Travel Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||